OR WAIT null SECS
Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.
October 02, 2016
Researchers develop catalysts that mediate complex transformations under conditions appropriate for commercial manufacture.
September 07, 2016
Drug companies and CDMOs seeking greener routes to the production of complex APIs may look to biocatalysis.
September 02, 2016
Researchers at GlaxoSmithKline report a greener and lower-cost route to chiral fluorolactams that is suitable for scale up.
August 03, 2016
Recent research of efficient chiral synthesis technologies reveals potential uses in API manufacturing.
August 02, 2016
Enzymatic catalysis offers pharma manufacturers a way to implement the Principles of Green Chemistry.
August 01, 2016
Multiple methods are required for detecting and removing protein impurities.